睿智医药 (300149.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(睿智医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 288,723,816.62288,795,947.15268,658,644.91294,346,941.60345,340,861.01300,594,594.81386,301,922.70
 营业收入(元) 288,723,816.62288,795,947.15268,658,644.91294,346,941.60345,340,861.01300,594,594.81386,301,922.70
二、营业总成本(元) 307,977,955.63277,931,897.57303,706,248.53414,170,877.07281,579,726.63344,311,769.57368,984,885.99
 营业成本(元) 220,299,181.24229,738,850.45195,703,134.23329,018,571.52210,359,091.30216,519,172.73233,431,931.86
 研发费用(元) 21,533,998.4316,367,554.1620,950,769.7612,000,870.7322,807,204.0029,072,004.5328,398,046.08
 营业税金及附加(元) 314,532.602,502,993.78276,531.67338,221.902,917,370.153,165,555.141,061,131.49
 销售费用(元) 11,925,879.2711,516,244.5510,187,537.9414,246,876.4010,980,117.3018,427,020.7118,191,596.33
 管理费用(元) 48,808,851.4134,047,220.7860,003,484.8127,507,766.0573,122,926.4277,826,470.8667,840,856.38
 财务费用(元) 5,095,512.68-16,240,966.1516,584,790.1231,058,570.47-38,606,982.54-698,454.4020,061,323.85
  其中:利息费用(元) 905,092.34771,669.402,609,317.7441,183,385.744,663,282.759,006,937.3011,627,153.46
  其中:利息收入(元) 2,742,897.011,595,016.867,068,700.945,691,055.885,516,616.65349,866.47256,677.36
 资产减值损失(元) -53,079.43-1,268,321.42-1,523,226.08-532,151,704.581,263,756.03-1,564,504.72-1,617,026.12
 信用减值损失(元) 1,737,691.99-2,645,662.60-443,594.50-16,839,621.522,535,401.73546,293.41-6,239,956.91
三、其他经营收益
 加:公允价值变动收益(元) -115,732.67------42,615.66
 加:投资收益(元) 2,033,221.414,949,982.513,280,955.0031,379,080.653,262,907.481,355,958,114.81440,243.17
  其中:对联营企业和合营企业的投资收益(元) 1,941,407.484,652,438.713,107,725.19-8,505,682.102,977,519.584,846,217.77364,801.93
 资产处置收益(元) -1,532,431.36--173,355.17-122,905.94-176,279.87-28,934.89
 其他收益(元) 1,013,351.911,675,490.711,903,168.292,190,270.653,855,268.751,505,973.221,620,590.34
四、营业利润(元) -16,171,117.1613,312,735.44-31,830,300.91-635,072,555.1074,555,562.431,312,552,422.0911,449,336.64
 加:营业外收入(元) 95,011.07102,190.01121,847.23143,404.5848,011.5369,169.1953,515.76
 减:营业外支出(元) 5,246.2560,060.00317.3018,450,084.09264,054.29312,147.3550,562.39
五、利润总额(元) -16,081,352.3413,354,865.45-31,708,770.98-653,379,234.6174,339,519.671,312,309,443.9311,452,290.01
 减:所得税费用(元) 3,422,833.356,604,534.27-3,113,174.84-8,529,304.987,649,058.76365,188,700.842,035,547.79
六、净利润(元) -19,504,185.696,750,331.18-28,595,596.14-644,849,929.6366,690,460.91947,120,743.099,416,742.22
(一)按经营持续性分类
  持续经营净利润(元) -19,504,185.696,750,331.18-28,595,596.14-644,849,929.6366,690,460.91947,120,743.099,416,742.22
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -19,427,860.346,791,005.22-28,566,911.66-644,806,821.9166,807,165.81947,113,666.409,470,996.67
  少数股东损益(元) -76,325.35-40,674.04-28,684.48-43,107.72-116,704.907,076.69-54,254.45
 扣除非经常性损益后的净利润(元) -19,773,046.233,789,018.04-32,668,068.66-635,032,433.2162,564,174.47-43,176,521.768,185,287.55
七、每股收益
 一、基本每股收益(元) -0.040.02-0.06-1.290.131.900.02
 二、稀释每股收益(元) -0.040.02-0.06-1.290.131.900.02
八、其他综合收益(元) 216,038.3815,200,286.38-5,414,466.45-5,645,694.1817,401,972.6412,671,776.24-858,641.86
 归属于母公司股东的其他综合收益(元) 216,038.3815,200,286.38-5,414,466.45-5,645,694.1817,401,972.6412,671,776.24-858,641.86
九、综合收益总额(元) -19,288,147.3121,950,617.56-34,010,062.59-650,495,623.8184,092,433.55959,792,519.338,558,100.36
 归属于母公司所有者的综合收益总额(元) -19,211,821.9621,991,291.60-33,981,378.11-650,452,516.0984,209,138.45959,785,442.648,612,354.81
 归属于少数股东的综合收益总额(元) -76,325.35-40,674.04-28,684.48-43,107.72-116,704.907,076.69-54,254.45
公告日期 2023-10-252023-08-292023-04-272023-04-272022-10-272022-08-302022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院